Legal & General Group
CRVO icon

Legal & General Group’s CervoMed CRVO Stock Holding History

Legal & General Group’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,515
Closed -$23K – 3444
2025
Q1 		$23K Buy
2,515
+401
+19% +$1.53K ﹤0.01% 2897
2024
Q4 		$4.95K Hold
2,114
– – ﹤0.01% 3336
2024
Q3 		$30.9K Hold
2,114
– – ﹤0.01% 2891
2024
Q2 		$36.2K Buy
+2,114
New +$46.2K ﹤0.01% 2840

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
AAS
Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal & General Group's CRVO Position: Q2 2025 in Review

Legal & General Group sold out of CervoMed (CRVO) in Q2 2025, closing a stake of 2,515 shares — an estimated $23K sold.

Legal & General Group first reported a position in CRVO in Q2 2024 and held it in 4 quarters. The position peaked at $36.2K in Q2 2024. 45 funds tracked by Wall St. Rank hold CRVO as of Q2 2025.

  • Legal & General Group reported no remaining CervoMed position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 2,515 CervoMed shares in Q2 2025, an estimated $23K.
  • Legal & General Group first reported a position in CervoMed in Q2 2024 and held it in 4 quarters.
  • Legal & General Group's CervoMed position peaked at $36.2K in Q2 2024.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.